Literature DB >> 23860721

Capsule commentary on Long and Stavert, portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.

J G Kahn1, E A Marseille.   

Abstract

Mesh：

Year:  2013        PMID： 23860721      PMCID： PMC3785660          DOI： 10.1007/s11606-013-2519-9

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  3 in total

1.  Evaluation of large-scale combination HIV prevention programs: essential issues.

Authors:  Nancy S Padian; Sandra I McCoy; Shanthi Manian; David Wilson; Bernhard Schwartländer; Stefano M Bertozzi
Journal:  J Acquir Immune Defic Syndr       Date:  2011-10-01       Impact factor: 3.731

2.  Portfolios of biomedical HIV interventions in South Africa: a cost-effectiveness analysis.

Authors:  Elisa F Long; Robert R Stavert
Journal:  J Gen Intern Med       Date:  2013-04-16       Impact factor: 5.128

3.  Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050.

Authors:  Reuben Granich; James G Kahn; Rod Bennett; Charles B Holmes; Navneet Garg; Celicia Serenata; Miriam Lewis Sabin; Carla Makhlouf-Obermeyer; Christina De Filippo Mack; Phoebe Williams; Louisa Jones; Caoimhe Smyth; Kerry A Kutch; Lo Ying-Ru; Marco Vitoria; Yves Souteyrand; Siobhan Crowley; Eline L Korenromp; Brian G Williams
Journal:  PLoS One       Date:  2012-02-13       Impact factor: 3.240
  3 in total
  1 in total

1.  Cervical Abnormalities in South African Women Living With HIV With High Screening and Referral Rates.

Authors:  Ingrid T Katz; Lisa M Butler; Tamaryn L Crankshaw; Alexi A Wright; Karen Bramhill; Dominick A Leone; Janet Giddy; Sean Mould
Journal:  J Glob Oncol       Date:  2016-05-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.